FDA
approval
· 2022-06-28
FDA Approved: OLMESARTAN MEDOXOMIL — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
Summary
FDA approved a supplemental application for olmesartan medoxomil filed by Quallent Pharmaceuticals Health LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)